GL Capital Group has been investing in healthcare and healthcare only for 15 years, managing nearly 24 billion yuan in healthcare assets. The firm has invested in 95 companies across diverse healthcare sub-sectors, such as pharmaceuticals, medical enterprises, healthcare services, in-vitro diagnostics (lVD), and contract research organizations (CROs), spanning the entire healthcare value chain, GL Capital partners with its portfolio companies to navigate challenges and seize opportunities in a continuously evolving industry and market, driving growth and value creation